CDEK
← All organizations

US Bioscience

For profitContributed to NME

Also known as: U.S. Bioscience

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 1

First clinical trial

Nov 2, 1999

First marketed drug

Dec 26, 1990

First NDA

Dec 26, 1990

Last known activity

Nov 2, 1999

Acquired by MedImmune → AstraZeneca on Jan 1, 1999

Timeline

1980s

  1. Jan 1, 1987

    US Bioscience— Founded

1990s

  1. Dec 8, 1995

    amifostine— NDA Organization

  2. Jan 1, 1999

    MedImmune— Acquired By

2000s

  1. Jun 19, 2007

    AstraZeneca— Now

Drugs by trial phase (5 distinct, 5 trials)

Indications

Approved for

Studied for

Marketed drugs (3)

Recent trials (5)

Details

Founded
Blue Bell, PA, US Jan 1, 1987
First NDA
Dec 26, 1990
Last known activity
Nov 2, 1999

Designations held

  • Orphan drug
  • Priority review